Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 15, 2019

SELL
$18.01 - $20.11 $19,630 - $21,919
-1,090 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$17.44 - $21.53 $19,009 - $23,467
1,090 New
1,090 $20,000
Q2 2018

Aug 14, 2018

SELL
$20.16 - $24.68 $144,668 - $177,103
-7,176 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$20.31 - $24.95 $145,744 - $179,041
7,176 New
7,176 $152,000

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.33B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.